Efficacy of memantine for agitation in Alzheimer's dementia: a randomised double-blind placebo controlled trial.
<h4>Background</h4>Agitation in Alzheimer's disease (AD) is common and associated with poor patient life-quality and carer distress. The best evidence-based pharmacological treatments are antipsychotics which have limited benefits with increased morbidity and mortality. There are no...
| Hoofdauteurs: | , , , , , , , , , |
|---|---|
| Formaat: | Artikel |
| Taal: | English |
| Gepubliceerd in: |
Public Library of Science (PLoS)
2012-01-01
|
| Reeks: | PLoS ONE |
| Online toegang: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22567095/pdf/?tool=EBI |